Krka d.d.

Summary

Company ID (NIN)

5043611000

Company owner / manager

Slovenska Drzavni Holding d.d.
Kapitalska Druzba d.d.

Country

Slovenia

Capital

54,732,000

Total assets

2,184,618,000

Net profit for the period

245,545,000

Report year

2019

Currency

EUR

Industry

Pharmaceuticals

Southeastern Europe Company Index (SEECI)

General information

About Krka d.d.

Krka d.d. is a Slovenian pharmaceuticals producer.

As of March 2021, the company’s shares are included in Ljubljana Stock Exchange’s blue-chip index SBITOP.

The company has an:

ISO 9001:2015 Quality management systems certificate, valid until Nov 30, 2021;
OHSAS 18001:2007 Occupational health and safety management systems certificate;
ISO 14001:2015 Environmental management systems certificate;
ISO 27001:2013 Information security management systems certificate.

Last updated on Aug 26, 2019.

Meta info

Status

Active

Legal form

Joint Stock Company

Incorporation date

July 13, 1989

NIN

5043611000

Tickers

KRKG

Stock Exchange

Ljubljana Stock Exchange

ISIN

SI0031102120

Profile last updated

March 10, 2021, 1:28 p.m.

Alternative names

Krka JSC
Krka, Tovarna Zdravil, d.d., Novo mesto
Krka d.d. Novo mesto
Krka

History

July 13, 1989 - Krka d.o.o. is established in Novo Mesto, southeastern Slovenia.

Feb 10, 1997 - The company lists on the Ljubljana Stock Exchange market. Later Krka d.o.o. transforms into a joint stock company from a limited liability company.

2007 - Krka d.d. acquires a 100% stake in Germany - based company TAD Pharma GmbH for EUR 97.0 mln.

Nov 6, 2008 - The company buys 100% in Austria - based pharmaceutical manufacturer Alternova Arzneimittel GMBH for EUR 1.3 mln.

July 16, 2020 - Krka d.d. takes over local Farma GRS d.o.o., which ceases to exist as a separate legal entity.

Last updated on Aug 26, 2019.

Related data

Similar companies

Related reports

Management

Board of Directors and Executives

Joze Colaric

Chairman of the Board and CEO

Vinko Zupancic

Member of the Board

Ales Rotar

Member of the Board

David Bratoz

Member of the Board

Milena Kastelic

Member of the Board

Supervisory Board

Joze Mermal

Chairman of the Board

Julijana Kristl

Member of the Board

Boris Znidaric

Member of the Board

Mateja Vrecer

Member of the Board

Franc Sasek

Deputy-Chairman of the Board

Borut Jamnik

Member of the Board

Matej Lahovnik

Deputy-Chairman of the Board

Videmsek Mojca Osolnik

Member of the Board

Tomaz Sever

Member of the Board

Contacts

Address

6, Smarjeska Str.
8000
Novo Mesto, Slovenia

Telephones

+386 7 331 21 11
+386 1 475 11 00

Fax

+386 7 332 15 37
+386 1 436 25 23

Emails

info@krka.biz

Websites

www.krka.si

Ownership

Name	Direct holding	Indirect holding	Owner type	Country
Slovenska Drzavni Holding d.d.	16.2		Company	Slovenia
Kapitalska Druzba d.d.	10.9		Company	Slovenia

Subsidiaries and affiliates

Name	Direct holding	Country
KRKA Belgium SA	95.0	Belgium
Farma GRS d.o.o.	99.7	Slovenia
KRKA Bulgaria EOOD	100.0	Bulgaria
Krka Farma DOO	100.0	Serbia
Krka Pharma GmbH	100.0	Austria
Krka Farma d.o.o.	100.0	Bosnia and Herzegovina
UAB Krka Lietuva	100.0	Lithuania
Krka-Polska Sp. z o.o.	100.0	Poland
Krka Farmaceutica Unipessoal Lda.	100.0	Portugal
OOO KRKA-Rus	100.0	Russia
Krka Hellas E.P.E	100.0	Greece
Krka-Farma d.o.o.	100.0	Croatia
KRKA Slovensko s.r.o.	100.0	Slovakia
Krka UK Ltd	100.0	UK
Krka USA LLC	100.0	USA
TOV Krka Ukraine	100.0	Ukraine
Terme Krka d.o.o.	100.0	Slovenia
Krka Romania SRL	100.0	Romania
OOO Krka Farma	100.0	Russia
Ningbo Krka Menovo Pharmaceutical Co. Ltd.	60.0	Japan
Krka France Eurl	100.0	France
TAD Pharma GmbH	100.0	Germany
Krka Pharma Dublin Limited	100.0	Ireland
Krka Farmaceutici Milano S.r.l.	100.0	Italy
Krka Farmaceutica S.L.	100.0	Spain
Krka Sverige AB	100.0	Sweden
Krka CR s.r.o.	100.0	Czech Republic
Krka Finland Oy	100.0	Finland
KRKA Magyarorszag Kft.	100.0	Hungary
TOO Krka Kazakhstan	100.0	Kazakhstan
SIA Krka Latvija	100.0	Latvia
Krka Farma DOOEL	100.0	N. Macedonia

Products and services

Krka d.d.'s basic line of business is the production and sale of prescription pharmaceuticals, non-prescription products and animal health products.

prescription pharmaceuticals products for:
- cardiovascular diseases;
- diseases of alimentary tract and metabolism;
- diseases of central nervous system;
- infections;
- oncology.
non-prescription products:
- products for the oral cavity and pharynx;
- cold and cough products;
- analgesic;
- nasal products;
- vitamin and mineral products;
- products for improving cerebral and peripheral circulation;
- products for the digestive tract and improving digestion;
- hair care products.
animal health products:
- analgesics;
- antimicrobials;
- antiparasitics;
- disinfectants;
- vitamins and minerals.